Literature DB >> 22151745

Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years.

Wulf Rössler1, Michael P Hengartner, Jules Angst, Vladeta Ajdacic-Gross.   

Abstract

AIMS: The aim of the study was to examine the temporal associations between substance use and subclinical psychosis symptoms.
DESIGN: Data from a prospective community study sampled within a single cohort over 30 years (1978-2008) were analysed with discrete-time hazard models.
SETTING: General population-based sample. PARTICIPANTS: At initial sampling in 1978 males (n = 292) were 19 and females (n = 299) were 20 years old. MEASUREMENTS: Two psychosis syndromes representing 'schizotypal signs' and 'schizophrenia nuclear symptoms' and various substance use variables including cannabis, alcohol, tobacco and multiple-drug use (i.e. cannabis combined with other drugs).
FINDINGS: In bivariate analyses, schizotypal signs were predominantly associated with regular cannabis use in adolescence (OR = 2.29, 95% CI 1.32-3.97). Schizophrenia nuclear symptoms were mainly related to alcohol (OR = 1.84, 95% CI 1.00-3.38) and multiple-drug use (OR = 2.35, 95% CI 1.38-4.02) during adolescence. Multivariate analyses showed that, in particular, regular cannabis use during adolescence was associated with the occurrence of subsequent schizotypal symptoms over a 30-year period (OR = 2.60, 95% CI; 1.59-4.23), whereas multiple-drug use in adolescence was associated predominantly with schizophrenia nuclear symptoms (OR = 1.75, 95% CI 1.01-3.03). Alcohol misuse was only slightly associated with the onset of such symptoms.
CONCLUSIONS: A significant portion of the occurrence of subclinical psychosis symptoms in adulthood can be attributed to excessive cannabis and multiple-drug use during adolescence. This is in line with the hypothesis that long-term sensitization of dopaminergic brain receptors plays a role in developing psychotic symptoms.
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2012        PMID: 22151745     DOI: 10.1111/j.1360-0443.2011.03760.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  24 in total

1.  Associations with quality of life and the effect of psychopathology in a community study.

Authors:  Jonathan Rogers; Michael P Hengartner; Jules Angst; Vladeta Ajdacic-Gross; Wulf Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

2.  Suicidality in the prospective Zurich study: prevalence, risk factors and gender.

Authors:  Jules Angst; Michael P Hengartner; Jonathan Rogers; Ulrich Schnyder; Hans-Christoph Steinhausen; Vladeta Ajdacic-Gross; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-30       Impact factor: 5.270

Review 3.  Dilemmas in the treatment of early-onset first-episode psychosis.

Authors:  Daniel Hayes; Marinos Kyriakopoulos
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-26

Review 4.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

Authors:  Boris B Quednow; Magdalena M Brzózka; Moritz J Rossner
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

5.  The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms.

Authors:  William V Lechner; Jennifer Dahne; Kevin W Chen; Alison Pickover; Jessica M Richards; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2013-01-03       Impact factor: 4.492

6.  Predictors of burnout: results from a prospective community study.

Authors:  Wulf Rössler; Michael P Hengartner; Vladeta Ajdacic-Gross; Jules Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-14       Impact factor: 5.270

7.  [Association between burnout and personality: results of the Zürich study].

Authors:  W Rössler; M P Hengartner; V Ajdacic-Gross; J Angst
Journal:  Nervenarzt       Date:  2013-07       Impact factor: 1.214

8.  Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland.

Authors:  W Rössler; V Ajdacic-Gross; H Haker; S Rodgers; M Müller; M P Hengartner
Journal:  Epidemiol Psychiatr Sci       Date:  2013-11-26       Impact factor: 6.892

9.  Treated versus non-treated subjects with depression from a 30-year cohort study: prevalence and clinical covariates.

Authors:  Michael P Hengartner; Felix Angst; Vladeta Ajdacic-Gross; Wulf Rössler; Jules Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-23       Impact factor: 5.270

10.  Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults.

Authors:  LaTrice Montgomery; Nancy M Petry; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2012-06-27       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.